comparison of glp 1 agonists GLP-1 for Weight Loss: A Side-by-Side glp-1 drugs comparison Market Overview:
Description
Tirzepatide has primarily gastrointestinal side effects that typically improve over time and carries no cardiovascular stimulant risks
43 In well-controlled type 1 diabetes, the prevalence of gastroparesis may be lower, attesting to the importance of glycaemic control
[DOI] [PubMed] [Google Scholar] [34].Brydon P, Smith T, Proffitt M, et al
2022, doi: 10.1016/j.ejmech.2022.114458
A., Wookey, P
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have also emerged as a potential therapy
